BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2859378)

  • 1. Pharmacological evidence for the involvement of alpha-2 adrenoceptors in the sedative effect of detomidine, a novel sedative-analgesic.
    Virtanen R; Ruskoaho H; Nyman L
    J Vet Pharmacol Ther; 1985 Mar; 8(1):30-7. PubMed ID: 2859378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the alpha 1- and alpha 2-adrenoceptor effects of detomidine, a novel veterinary sedative analgesic.
    Virtanen R; Nyman L
    Eur J Pharmacol; 1985 Jan; 108(2):163-9. PubMed ID: 2984021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive activity and mechanism of action of detomidine.
    Virtanen R
    J Vet Pharmacol Ther; 1986 Sep; 9(3):286-92. PubMed ID: 3761419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular action of detomidine, a sedative and analgesic imidazole derivative with alpha-agonistic properties.
    Savola JM; Ruskoaho H; Puurunen J; Kärki NT
    Eur J Pharmacol; 1985 Nov; 118(1-2):69-76. PubMed ID: 2867913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of detomidine and xylazine on some alpha 2-adrenoceptor-mediated responses in the central and peripheral nervous systems.
    Virtanen R; MacDonald E
    Eur J Pharmacol; 1985 Sep; 115(2-3):277-84. PubMed ID: 2998825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine.
    Timmermans PB; Schoop AM; Kwa HY; Van Zwieten PA
    Eur J Pharmacol; 1981 Mar; 70(1):7-15. PubMed ID: 6111465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of detomidine on the release and turnover of noradrenaline in rat brain.
    Virtanen R; MacDonald E; Kaisila M
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):348-54. PubMed ID: 3739728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of sedative and clinicophysiological effects of epidural xylazine and detomidine with atipamezole and yohimbine in buffaloes (Bubalus bubalis).
    Tiwari SK; Kumar A; Vainio O
    Vet Rec; 1998 Nov; 143(19):529-32. PubMed ID: 9839365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the sedative effects of three alpha 2-adrenoceptor agonists (romifidine, detomidine and xylazine) in the horse.
    England GC; Clarke KW; Goossens L
    J Vet Pharmacol Ther; 1992 Jun; 15(2):194-201. PubMed ID: 1359161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and sedative alpha-adrenoceptor effects of detomidine-like arylalkyl imidazoles and associated derivatives.
    Savola JM; Ruskoaho H; Salonen JS; Puurunen J; Karjalainen A; Kurkela K; Kärki NT
    Arzneimittelforschung; 1988 Jan; 38(1):29-35. PubMed ID: 2835056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha-adrenoceptor antagonists on the mydriatic and bradycardic effects of detomidine.
    Hanson CE; Hsu WH
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):291-8. PubMed ID: 2888443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors.
    Savola JM; Ruskoaho H; Puurunen J; Salonen JS; Kärki NT
    J Auton Pharmacol; 1986 Dec; 6(4):275-84. PubMed ID: 2880852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of alpha-2 and alpha-1 adrenoceptors in the experimentally-induced depression of the central nervous system.
    Harsing LG; Kapocsi J; Vizi ES
    Pharmacol Biochem Behav; 1989 Apr; 32(4):927-32. PubMed ID: 2572006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the sedative effects of 2 alpha-sympathomimetic antihypertensive agents: clonidine and tiamenidine].
    Simon P; Chermat R; Boissier JR
    Therapie; 1975; 30(6):855-61. PubMed ID: 8853
    [No Abstract]   [Full Text] [Related]  

  • 16. Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypes.
    Schwartz DD; Clark TP
    J Vet Pharmacol Ther; 1998 Apr; 21(2):107-11. PubMed ID: 9597647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of xylazine, detomidine, acepromazine and butorphanol on equine solid phase gastric emptying rate.
    Sutton DG; Preston T; Christley RM; Cohen ND; Love S; Roussel AJ
    Equine Vet J; 2002 Jul; 34(5):486-92. PubMed ID: 12358052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedative effects of midazolam and xylazine with or without ketamine and detomidine alone following intranasal administration in Ring-necked Parakeets.
    Vesal N; Eskandari MH
    J Am Vet Med Assoc; 2006 Feb; 228(3):383-8. PubMed ID: 16448361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of intranasal benzodiazepines, alpha-agonists and their antagonists in canaries.
    Vesal N; Zare P
    Vet Anaesth Analg; 2006 May; 33(3):143-8. PubMed ID: 16634939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist.
    Virtanen R; Savola JM; Saano V; Nyman L
    Eur J Pharmacol; 1988 May; 150(1-2):9-14. PubMed ID: 2900154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.